MPLT · Categories · Downgrades

MPLT - Analyst downgrades

MapLight Therapeutics Inc. (MPLT) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for MPLT

• 24d
  MapLight Therapeutics downgraded by UBS with a new price target

  UBS downgraded MapLight Therapeutics from Buy to Neutral and set a new price target of $13.00
• 37d
  MapLight Therapeutics downgraded by Morgan Stanley with a new price target

  Morgan Stanley downgraded MapLight Therapeutics from Overweight to Equal-Weight and set a new price target of $21.00

Other MPLT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings